Healthcare ❯ Clinical Trials

Phase 3 Trials

Drug Efficacy Checkpoint Inhibitors Patient Adherence SYNCHRONY Programme Intervention Studies Solid Tumors Treatment Efficacy Efficacy and Safety Regulatory Milestones

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

The company plans to seek FDA review later this year following the positive late-stage result.

FDA Grants National Priority Voucher to J&J’s Tecvayli–Darzalex Combo in Multiple Myeloma

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Weekly Oral Risperidone Pill Maintains Steady Levels in Phase 3 Schizophrenia Trial

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma